99% Decline in FSD PriceIs it a cigar butt , or just plain junk?
Is it another one to add to the list?
FSD Pharma: A Rollup With Scattered, Uneconomical Cannabis Investments, 50-70% Downside FSD Pharma’s founder, Thomas Fairfull, and director, Anthony Durkacz, have a history of value destruction. Durkacz had an average loss of 92% over 11 stocks in which he had involvement.
The company spent $8 million on listing fees, which is a head-scratcher, as it is multiple times larger than what comps spend.
Durkacz has received an astounding sum of over C$28.7 million total current value in cash and warrants for being both a director and broker for FSD.
FSD Pharma routinely announces investing in other small cannabis companies, but so far has shown little follow-through.
We have a price target on FSD of C$0.09 per share, which was its pre-RTO financing price less than a year ago.
https://whitediamondresearch.com/research/fsd-pharma-a-rollup-with-scattered-uneconomical-cannabis-investments-50-70-downside/